Syntaxin 4, a key player in vesicular transport and membrane fusion, is an integral component of the SNARE complex. Direct chemical inhibition of Syntaxin 4 is challenging due to its essential role in these fundamental cellular processes. However, targeting associated pathways and processes can offer an indirect approach to modulate its function. The compounds listed, such as Tetanus toxin, Botulinum toxins, and N-Ethylmaleimide, target aspects of the SNARE complex formation or function. Tetanus toxin and various types of Botulinum toxins cleave or interfere with SNARE proteins, potentially disrupting Syntaxin 4's role in vesicular docking and fusion. N-Ethylmaleimide's ability to modify sulfhydryl groups can inhibit SNARE complex formation, thereby impacting Syntaxin 4.
Other chemicals like Dynasore, Brefeldin A, and Monensin affect different aspects of vesicle formation, trafficking, and fusion. Dynasore's inhibition of dynamin and Brefeldin A's disruption of the Golgi apparatus can indirectly impact the vesicular transport processes involving Syntaxin 4. Similarly, Monensin's alteration of Golgi function can influence Syntaxin 4-mediated vesicle trafficking. Additionally, compounds that affect cytoskeletal dynamics, such as Latrunculin A and Jasplakinolide, can indirectly modulate Syntaxin 4's function. The cytoskeleton plays a critical role in vesicle transport, and altering actin dynamics can impact the processes in which Syntaxin 4 is involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
NEM modifies sulfhydryl groups and can inhibit SNARE complex formation, potentially impacting Syntaxin 4 function. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
While primarily a Rac1 inhibitor, NSC 23766 can affect cellular transport processes, potentially influencing Syntaxin 4 function indirectly. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, a GTPase involved in vesicle scission, potentially affecting Syntaxin 4-mediated vesicle transport. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus, potentially affecting the trafficking of vesicles where Syntaxin 4 is involved. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin alters Golgi function and vesicle trafficking, which could indirectly influence Syntaxin 4 activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, potentially affecting protein trafficking and indirectly impacting Syntaxin 4 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3 kinase inhibitor, can affect vesicular trafficking pathways, potentially influencing Syntaxin 4's role in these processes. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A disrupts actin polymerization, which is crucial for vesicle transport, potentially affecting Syntaxin 4 function. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can influence vesicle transport, potentially impacting Syntaxin 4's role in membrane fusion. | ||||||